breast cancer prognosis analysis device
Scope
Date
~
-
Bio & Pharma
Celltrion unveils cancer medicine to expand new drug pipelines
South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...
Apr 28, 2025 (Gmt+09:00)
-
Korean chipmakers
DB GlobalChip forays into mobile phone OLED driver chip market
DB GlobalChip Co., the chip design subsidiary of South Korea’s chip foundry company DB HiTek Co., has begun mass-producing organic light-emitt...
Apr 02, 2025 (Gmt+09:00)
-
Leadership & Management
Samsung mobile chief fills leadership void in device division
Samsung Electronics Co. has appointed TM Roh, president and head of its mobile eXperience (MX) business, as the new chief of its device eXperience (...
Apr 02, 2025 (Gmt+09:00)
-
Mergers & Acquisitions
KKR, Carlyle, Hillhouse race to buy Korean beauty device maker Classys
Global private equity giants such as KKR & Co., Carlyle Group and Hillhouse Capital Group Holdings are vying to acquire Classys Inc. as the Sout...
Mar 26, 2025 (Gmt+09:00)
-
Bio & Pharma
SillaJen: First to use lab-grown human tissue to find best cancer drug dose
South Korean biotechnology firm SillaJen Inc. is pioneering a new approach to determine the best dose for a cancer drug combination in clinical tria...
Mar 18, 2025 (Gmt+09:00)
-
Medical devices
Middle East: New land of opportunity for Korean medical devices
South Korea is making inroads into the Middle East's medical device market dominated by the US and Europe, aiming to leverage the region’s str...
Feb 10, 2025 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Vegzelma: Most-prescribed cancer treatment in Europe
South Korea’s leading biosimilar drug developer Celltrion Inc.'s Vegzelma, a cancer drug referencing global biopharma Roche’s Avastin, h...
Feb 05, 2025 (Gmt+09:00)
-
Bio & Pharma
Partners Investment, GordonMD eye $150 mn biotech fund launch
South Korean venture capital firm Partners Investment said on Thursday it will raise up to 215.5 billion won ($150 million) in a biotech fund jointl...
Jan 23, 2025 (Gmt+09:00)
-
Bio & Pharma
Yuhan’s lung cancer drug gets OK in Europe
Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...
Dec 31, 2024 (Gmt+09:00)
-
Artificial intelligence
SK Telecom invests $3 mn in AI-powered video analysis startup Twelve Labs
South Korea’s top mobile carrier SK Telecom Co. said on Friday it will invest $3 million in Twelve Labs Inc., a Korean AI-powered video analys...
Dec 13, 2024 (Gmt+09:00)
-
Bio & Pharma
President of Latvia visits S.Korea's Daan Cancer Lab
Daan Cancer Laboratory under Severance Hospital said on Thursday it signed a memorandum of understanding (MOU) with the Latvian government to streng...
Nov 28, 2024 (Gmt+09:00)
-
Bio & Pharma
Korea’s Lunit in AI-powered lung cancer diagnostics deal with AstraZeneca
Lunit Inc., a South Korean AI-powered cancer diagnostics company, has partnered with global biopharma giant AstraZeneca plc. to jointly enter the AI...
Nov 18, 2024 (Gmt+09:00)
-
Bio & Pharma
GC establishes generative AI platform Hey GC
South Korea's Green Cross Holdings Corp. (GC) said on Tuesday it established its generative AI standard platform Hey.GC.Hey.GC is designed to improv...
Nov 12, 2024 (Gmt+09:00)
-
Artificial intelligence
LG’s telecom unit to spend $2.1 bn on transition into AX company
LG Uplus Corp., South Korea’s No. 3 mobile carrier, plans to invest up to 3 trillion won ($2.1 billion) in artificial intelligence and foster ...
Nov 07, 2024 (Gmt+09:00)
-
Bio & Pharma
Volpara to supply breast cancer SW to US Defense Health Agency
Lunit, a South Korean cancer diagnostics AI company, said on Monday its US subsidiary Volpara Health secured a 10 billion won ($7.5 million) contr...
Nov 05, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Bain Capital puts beauty device maker Classys on market
Bain Capital has embarked on the process to sell a majority stake in Classys Inc., a South Korean medical aesthetic device maker. The deal is estima...
Oct 21, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion's anti cancer drugs hold 90% market share in C.America
South Korea’s Celltrion Inc. said on Friday that its cancer treatments have captured a 90% market share in several Central American countries....
Oct 11, 2024 (Gmt+09:00)
-
Banking & Finance
Mirae Asset Securities builds AI-based stock analysis system
South Korea's Mirae Asset Securities Co. said on Monday that it has established an AI Market Assistant system, in which artificial intelligence (AI)...
Oct 07, 2024 (Gmt+09:00)
-
Artificial intelligence
LG Innotek develops AI for raw material inspection
LG Innotek, a leading South Korean electronics parts maker, said on Wednesday it developed an artificial intelligence (AI) system that can filter ou...
Sep 25, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to supply breast, stomach cancer treatment to Brazil
Celltrion Inc., South Korea’s largest biosimilar maker, announced on Friday that its breast and stomach cancer treatment "Herzuma" (active ing...
Sep 13, 2024 (Gmt+09:00)
-
Korean chipmakers
Samsung mass-produces QLC V9 NAND to lead AI storage market
Samsung Electronics Co., the world’s largest memory chipmaker, said on Thursday it has begun mass production of a 286-layer high-capacity NAND...
Sep 12, 2024 (Gmt+09:00)
-
Human Interest
After 37 years of use, Kim returns trusty microwave to Samsung with love
For 37 years, a simple microwave made by Samsung Electronics Co. sat in the kitchen of Kim Kyu-won, providing much more than convenience.It was ther...
Sep 11, 2024 (Gmt+09:00)
-
Tech, Media & Telecom
KT applies AIoT video surveillance to EV charging stations
South Korea's KT Corp. said on Monday that it will expand its Artificial Intelligence Internet of Things (AIoT) video surveillance business to elect...
Sep 09, 2024 (Gmt+09:00)
-
Artificial intelligence
Pulley Campus, Yonsei Univ. to co-work on educational AI services
Freewheelin, which operates the AI courseware Pulley Campus for university education, said on Friday that it signed an industry-academia cooperation...
Sep 06, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Group’s 3rd-generation daughter comes to the fore
Chey Yoon-chung, the eldest daughter of SK Group Chairman Chey Tae-won, unexpectedly made her debut during an SK Biopharmaceuticals Co. video confer...
Aug 30, 2024 (Gmt+09:00)
-
Electronics
LG Elec to unveil AI home hub ThinQ ON at IFA
LG Electronics Inc. said on Thursday that it will unveil LG ThinQ ON, the home appliance industry's first AI home hub equipped with generative artif...
Aug 29, 2024 (Gmt+09:00)
-
Bio & Pharma
Gencurix, Hitachi to cooperate on molecular diagnostics
South Korean biotech company Gencurix Inc. said on Tuesday that it will cooperate with Japan's Hitachi High-Tech Corporation to enter the Japanese c...
Aug 29, 2024 (Gmt+09:00)
-
Beauty & Cosmetics
APR, TJX to co-work for Medicube products sale in N.Amerca
South Korea's cosmetic and clothing company APR said on Wednesday it signed a supply contract with TJX Companies, the North America-based global ret...
Aug 28, 2024 (Gmt+09:00)
-
Bio & Pharma
Volpara to supply cancer diagnostics SW to Intermountain Health
Lunit, a South Korean cancer diagnostics AI company, announced on Wednesday that its subsidiary Volpara Health, a New Zealand-based AI software deve...
Aug 21, 2024 (Gmt+09:00)
-
Bio & Pharma
Yuhan’s lung cancer drug clears FDA hurdle for global debut
A new lung cancer treatment developed by South Korea’s Yuhan Corp. has secured approval from the US Food and Drug Administration (FDA) as a co...
Aug 21, 2024 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand